Atypical Depression Completed Phase 4 Trials for Duloxetine (DB00476)

IndicationStatusPhase
DBCOND0033164 (Atypical Depression)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00296699
A Pilot Study Assessing Duloxetine's Efficacy in Atypical DepressionTreatment